Loss-of-function mutations in PPAR gamma associated with human colon cancer

Citation
P. Sarraf et al., Loss-of-function mutations in PPAR gamma associated with human colon cancer, MOL CELL, 3(6), 1999, pp. 799-804
Citations number
28
Categorie Soggetti
Cell & Developmental Biology
Journal title
MOLECULAR CELL
ISSN journal
10972765 → ACNP
Volume
3
Issue
6
Year of publication
1999
Pages
799 - 804
Database
ISI
SICI code
1097-2765(199906)3:6<799:LMIPGA>2.0.ZU;2-O
Abstract
The gamma isoform of the peroxisome proliferator-activated receptor, PPAR g amma, regulates adipocyte differentiation and has recently been shown to be expressed in neoplasia of the colon and other tissues. We have found four somatic PPAR gamma mutations among 55 sporadic coln cancers: one nonsense, one frameshift, and two missense mutations. Each greatly impaired the funct ion of the protein. c.472delA results in deletion of the entire ligand bind ing domain. Q286P and K319X retain a total or partial ligand binding domain but lose the ability to activate transcription through a failure to bind t o ligands. R288H showed a normal response to synthetic ligands but greatly decreased transcription and binding when exposed to natural ligands. These data indicate that colon cancer in humans is associated with loss-of-functi on mutations in PPAR gamma.